When to Test for Anti-Interferon-γ Autoantibody?
Clin Infect Dis
.
2020 Oct 23;71(7):e199.
doi: 10.1093/cid/ciaa129.
Authors
Kent Mun Loh
1
,
Youjia Zhong
1
,
Li Lin
2
,
Monica Chan
3
4
,
Benjamin Pei Zhi Cherng
5
,
Haur Sen Yew
3
4
,
Haoyang Sun
6
,
Borame Sue Lee Dickens
6
,
David Chien Boon Lye
3
4
7
8
,
Chiung Hui Huang
9
,
Ai Leng Khoo
10
,
Louis Yi Ann Chai
7
11
Affiliations
1
Khoo Teck-Puat-National University Children's Medical Institute, National University Health System, Singapore.
2
Department of Medicine, Ng Teng Fong Hospital, Jurong Campus, National University Health System, Singapore.
3
Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore.
4
National Centre for Infectious Diseases, Singapore.
5
Department of Infectious Diseases, Singapore General Hospital, Singapore.
6
Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
7
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
8
Lee Kong Chian School of Medicine, Singapore.
9
Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
10
Pharmacy and Therapeutics Office, Group Health Informatics, National Healthcare Group, Singapore.
11
Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore.
PMID:
32052830
DOI:
10.1093/cid/ciaa129
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Autoantibodies*
Humans
Immunologic Deficiency Syndromes*
Interferon-gamma
Thailand
United States
Substances
Autoantibodies
Interferon-gamma